INFLUENCE OF ESTROGEN ON PROSTACYCLIN AND THROMBOXANE BALANCE IN POSTMENOPAUSAL WOMEN

Citation
Fz. Stanczyk et al., INFLUENCE OF ESTROGEN ON PROSTACYCLIN AND THROMBOXANE BALANCE IN POSTMENOPAUSAL WOMEN, Menopause, 2(3), 1995, pp. 137-143
Citations number
31
Categorie Soggetti
Obsetric & Gynecology","Reproductive Biology
Journal title
ISSN journal
10723714
Volume
2
Issue
3
Year of publication
1995
Pages
137 - 143
Database
ISI
SICI code
1072-3714(1995)2:3<137:IOEOPA>2.0.ZU;2-3
Abstract
Although the cardioprotective effect of estrogen is well recognized, t he mechanism by which this effect occurs is not well understood. One p ossible mechanism may involve an alteration in the local vascular equi librium between prostacyclin (PGI(2)) and thromboxane A(2) (TxA(2)), f avoring PGI(2). To test this hypothesis, we studied the estrogenic eff ect on urinary PGI(2)/TxB(2) balance, both acutely and long term, in p ostmenopausal women. Seven subjects received estradiol (E(2)) during o ne visit and only the vehicle during another visit (control). Both wer e administered intravenously for 8 h. Serum E(2) levels of similar to 200 pg/ml were attained after E(2) treatment. An additional eight subj ects were treated subcutaneously with two 25-mg E(2) pellets for 24 we eks; the serum E(2) levels averaged between 80 and 120 pg/ml. Also, 12 premenopausal women were used for comparison of baseline prostanoid v alues with those of postmenopausal women. A highly specific and sensit ive high-performance liquid chromatography/radioimmunoassay (HPLC-RIA) was used to quantitate PGI(2) and TxA(2) by measuring their stable me tabolites, 6-keto-prostaglandin F-1 alpha (6-keto-PGF(1 alpha)) and th romboxane B-2 (TxB(2)), respectively, in urine. The 6-keto-PGF(1 alpha ) and TxB(2) levels in postmenopausal women were 35.6 +/- 6.5 and 20.5 +/- 3.8 ng/g of creatinine compared with 32.2 +/- 5.3 and 16.7 +/- 3. 9 ng/g in premenopausal women, respectively. After E(2) infusion, ther e was a significant increase (41%) in mean 6-keto-PGF(1 alpha) levels, a 35% drop in mean TxB(2) levels, and a significantly greater (65%) 6 -keto-PGF(1 alpha)/TxB(2) ratio, compared to the controls. After long- term E(2) treatment, there was a progressive decrease in mean TxB(2) l evels and a transient increase in 6-keto-PGF(1 alpha) levels. The resu lts of our study suggest that the anticipated effects of E(2) treatmen t on PGI(2) and TxA(2) metabolism in postmenopausal women do occur.